Clinical Trial

To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia

Study acronym: TRD205
Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 17, 2025 (before its estimated April 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a phase II, multicenter ,randomized, double-blind, placebo-controlled, dose-finding study designed to evaluate the efficacy and safety of TRD205 tablets in the treatment of chronic postoperative neuralgia
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-07.
Trial Details
NCT Number NCT07123402
Lead Sponsor Beijing Tide Pharmaceutical Co., Ltd
Collaborators: China-Japan Friendship Hospital
Conditions Chronic Postoperative Neuralgia
Enrollment 184 participants
Start Date 2025-04-09
Primary Completion 2026-04-20 (estimated)
Study Completion 2026-05-27 (estimated)
Updated on ClinicalTrials.gov 2025-08-17